Skip to main content
Beijing SL Pharmaceutical Co., Ltd. logo

Beijing SL Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002038 ISIN · CNE000001L31 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,472 across all filing types
Latest filing 2019-06-12 Director's Dealing
Country CN China
Listing Shenzhen Stock Exchange 002038

About Beijing SL Pharmaceutical Co., Ltd.

https://www.slpharm.com.cn

Beijing SL Pharmaceutical Co., Ltd. specializes in the research, development, manufacturing, and commercialization of pharmaceutical products. The company focuses on several therapeutic areas, including cardiovascular and cerebrovascular diseases, oncology, and infectious diseases. Its product portfolio features a range of chemical drugs and active pharmaceutical ingredients (APIs), with key offerings such as clopidogrel bisulfate and amlodipine besylate. Operating with advanced production facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company emphasizes technological innovation and quality control. The organization serves both domestic and international markets, leveraging its integrated R&D platform to develop generic medications and innovative formulations aimed at improving patient outcomes.

Recent filings

Filing Released Lang Actions
关于董事长增持公司股份的公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the increase in shareholding by the company's chairman, Mr. Xu Mingbo. It details the number of shares purchased, the date of purchase, the price, and the resulting total shareholding percentage. The document references compliance with relevant laws and regulations concerning shareholding changes by directors and senior management. There is no financial report, earnings data, or meeting materials. The content fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on this shareholding change, confirming it is not a full financial report or other category. Therefore, the correct classification is Director's Dealing (DIRS).
2019-06-12 Chinese
2018年度股东大会的法律意见
Regulatory Filings Classification · 90% confidence The document contains only placeholders for images and no textual content or financial data. It is extremely short (385 characters) and does not provide any substantive information or report content. Therefore, it cannot be classified as a financial report or detailed filing. Given the lack of content, the best fit is Regulatory Filings (RNS) as a fallback category for miscellaneous or non-informative filings.
2019-05-22 Chinese
2018年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2018年度股东大会决议公告" which translates to "2018 Annual General Meeting Resolution Announcement." It details the resolutions passed at the 2018 Annual General Meeting (AGM) of Beijing Shuanglu Pharmaceutical Co., Ltd., including voting results on various proposals such as the 2018 board work report, supervisory board report, financial report, profit distribution plan, and appointment of auditors. The document includes attendance details, voting methods, and legal opinions on the meeting's validity. It does not contain the full annual report or financial statements but rather the official announcement of the AGM resolutions and voting outcomes. The document length is about 4846 characters, which is consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-05-22 Chinese
公司章程（2019年5月）
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Beijing SL Pharmaceutical Co., Ltd. It contains detailed provisions about the company's organization, shareholder rights, board structure, share issuance, shareholder meetings, voting procedures, and other governance matters. It is a comprehensive governance document that outlines the internal rules and regulations governing the company. There is no indication that this is a financial report, audit report, or announcement of voting results. It is not a presentation or call transcript. The content aligns with the definition of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2019-05-06 Chinese
独立董事关于增加公司经营范围暨修改《公司章程》的独立意见
Board/Management Information Classification · 90% confidence The document is an independent director's opinion regarding the amendment of the company's articles of association and expansion of business scope. It references compliance with regulatory guidelines and is intended to be submitted to the 2018 annual general meeting for approval. The document is short (507 characters) and serves as a formal opinion rather than a full report or announcement of voting results. It does not contain financial data or detailed governance rules but relates to governance matters. Therefore, it fits best under Board/Management Information (MANG) as it concerns board-level opinions on company governance changes.
2019-05-06 Chinese
第七届监事会第六次临时会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of a resolution passed at a supervisory board meeting regarding the increase of the company's business scope and amendments to the company's articles of association. It mentions the meeting details, attendance, and the approval of the proposal to be submitted to the annual general meeting. There is no financial data, no audit or annual report content, no earnings information, and no presentation or call transcript. The document is a corporate governance-related announcement about board/supervisory decisions and company internal rules amendments. This fits best under Board/Management Information (MANG) as it relates to board resolutions and governance changes, but since it specifically concerns the supervisory board's resolution and amendments to the articles of association, it aligns with governance or board/management information. Given the options, MANG is the closest fit as it covers board/management announcements. The document is short and does not contain financial statements or detailed governance reports, so it is not AGM Information or Governance Information. Therefore, the classification is MANG with high confidence.
2019-05-06 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.